retroviruses two of which-the oncovirinae and lentivirinae-are pathogenic. As these names suggest some of the viruses are associated with tumours, especially leukaemias and lymphomas, and cause diseases of prolonged incubation. Of particular interest to the neurologist is the fact that a given retrovirus can be associated with two distinct pathological processes in a host species, one of which frequently involves the nervous system. For example the viruses causing murine leukaemia, ovine pneumonitis, caprine arthritis, equine infectious anaemia and simian immune deficiency are all associated with meningoencephalitides of various types. These disorders, with the exception of simian immune deficiency syndrome, have been well recognised by veterinary clinicians for decades and ovine visna/maedi ( Kayembe and colleagues are the first to obtain evidence of such clustering. They show that half the 21 families they studied contains another member with TSP. Further, in seven families it was the mother and her child who were affected while there was no case of both the father and child having the disease. This suggests that the transmission of HTLV 1 occurs from the mother to her offspring, an observation supported by studies of HTLV 1 antibodies in families with ATL in Japan'4 and also by similar studies of TSP families in the United Kingdom (unpublished data). Although Kayembe et al have no data on the mode of transmission it does seem that in Japan, apart from the known risks of blood transfusion, breast milk is the source ofinfection in infants and semen the main cause ofinfection in adults."
The second reason why this paper is important concerns genetic susceptibility to TSP. It is known that HTLV 1 is widespread in areas where TSP and ATL are endemic but that the vast majority of carriers are asymptomatic. From work with murine leukaemia virus there is evidence that both the host and viral genetic constitution can be important in determining whether a carrier develops leukaemia or myelopathy.'6 In humans there is no good evidence that there is a specific neurogenic mutant of HTLV 1 causing TSP7 18 but there is some, not very convincing, evidence from Japan to suggest that certain host HLA phenotypes are associated with TSP (HAM) while individuals with other phenotypes are susceptible to ATL.'9 The paper by Kayembe and co-worker's addresses this problem. Their study area contained three tribes of which one accounted for only 10% of the total population, but 50% of the patients with TSP came from this group. The authors point out that since there is a significantly non-random distribution of TSP within these tribes but HTLV 1 infection is widespread these observations bear witness to genetic factors playing an important part in determining whether a patient develops TSP or remains asymptomatic. Further studies involving HLA typing are in progress to confirm or refute this hypothesis; the results are eagerly awaited.
The initial chance observation that TSP is associated with a retrovirus has probably been the most significant advance in neurology in the past five years. How such an infection leads to neurological damage is at present mysterious. Hopefully, further work will enable a clearer picture of the pathogenesis of TSP to emerge and perhaps lead to the discovery of novel retroviruses that cause some of the many diseases of obscure origin confronting the neurologist.
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